Unraveling the role of IL-17 signaling pathway in breast cancer-related depression: insights from in vivo/in vitro models and transcriptomic analysis | Synapse
March 3, 2026
Unraveling the role of IL-17 signaling pathway in breast cancer-related depression: insights from in vivo/in vitro models and transcriptomic analysis
Key Points
Breast cancer-related depression is influenced by the il-17 signaling pathway, revealing critical biological connections.
Key findings include significant alterations in transcriptomic profiles associated with depression in cancer models.
Analysis using in vivo and in vitro models highlights the importance of the il-17 pathway in the context of breast cancer.
These insights may enable better understanding and targeted therapies for depression in breast cancer patients.